Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 14 matching records.
14 results — page 1 of 1
- Level BClinical TrialPubMed
Isolation of SSEA-3-Positive Muse Cells in Canine and Feline Adipose Tissues.
Clinical Trial on Systemic / IV, published in Stem Cells Dev (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cells Dev - Level DNarrative ReviewEurope PMC
Endogenous reparative pluripotent Muse cells with a unique immune privilege system: Hint at a new strategy for controlling acute and chronic inflammation
Narrative Review on Cardiovascular Disease, Stroke Research, Spinal Cord Injury, Chronic Inflammation, published in Front Pharmacol (2022) — summary generated from the PubMed abstract.
- 2022
Front Pharmacol18 citations - Level BClinical TrialEurope PMC
Cell-based treatment for perinatal hypoxic-ischemic encephalopathy
Clinical Trial, published in Brain Circ (2021) — summary generated from the PubMed abstract.
- 2021
Brain Circ17 citations - Level CProspective StudyEurope PMC
Congress report: A report of the 16th Congress of the Japanese Society for Regenerative Medicine
Prospective Study with a reported sample of 3527 on Hair & Scalp, published in Regen Ther (2018) — summary generated from the PubMed abstract.
- 2018
- n = 3527
Regen Ther - Level DNarrative ReviewPubMed
Protocols for Isolation and Evaluation of Muse Cells.
Narrative Review, published in Adv Exp Med Biol (2018) — summary generated from the PubMed abstract.
- 2018
Adv Exp Med Biol6 citations - Level BClinical TrialPubMed
Clinical Trials of Muse Cells.
Clinical Trial on Systemic / IV, published in Adv Exp Med Biol (2018) — summary generated from the PubMed abstract.
- 2018
Adv Exp Med Biol - Level DNarrative ReviewPubMed
Muse Cells Provide the Pluripotency of Mesenchymal Stem Cells: Direct Contribution of Muse Cells to Tissue Regeneration.
Narrative Review on Systemic / IV, published in Cell Transplant (2016) — summary generated from the PubMed abstract.
- 2016
Cell Transplant - Level DLaboratory StudyPubMed
The secretome of MUSE cells contains factors that may play a role in regulation of stemness, apoptosis and immunomodulation.
Laboratory Study on Immune Modulation, published in Cell Cycle (2016) — summary generated from the PubMed abstract.
- 2016
Cell Cycle60 citations - Level DNarrative ReviewPubMed
Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues.
Narrative Review, published in Pathol Int (2014) — summary generated from the PubMed abstract.
- 2014
Pathol Int - Level DNarrative ReviewPubMed
Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine.
Narrative Review, published in Anat Rec (Hoboken) (2013) — summary generated from the PubMed abstract.
- 2013
Anat Rec (Hoboken) - Level DNarrative ReviewEurope PMC
Muse cells and induced pluripotent stem cell: implication of the elite model
Narrative Review, published in Cell Mol Life Sci (2012) — summary generated from the PubMed abstract.
- 2012
Cell Mol Life Sci18 citations - Level CProspective StudyEurope PMC
Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy
Prospective Study on Neuroinflammation, published in Parkinsons Dis (2012) — summary generated from the PubMed abstract.
- 2012
Parkinsons Dis33 citations - Level DLaboratory StudyPubMed
Regenerative Effects of Mesenchymal Stem Cells: Contribution of Muse Cells, a Novel Pluripotent Stem Cell Type that Resides in Mesenchymal Cells.
Laboratory Study on Immune Modulation, published in Cells (2012) — summary generated from the PubMed abstract.
- 2012
Cells61 citations - Level DNarrative ReviewPubMed
Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells?
Narrative Review on Cardiovascular Disease, Chronic Wound, published in Arch Immunol Ther Exp (Warsz) (2011) — summary generated from the PubMed abstract.
- 2011
Arch Immunol Ther Exp (Warsz)
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406